Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Incidence and Outcomes of Pneumocystis Pneumonia Following Chimeric Antigen Receptor T-Cell Therapy: A Real-World Analysis

Jiasheng Wang, Michael Daunov, Brenda W Cooper

Blood (2023) 142 (Supplement 1): 6897.

https://doi.org/10.1182/blood-2023-190785

Published: 2023

Journal Articles

Social Determinants of Health (SDoH) Scores for Adolescent and Young Adults (AYAs) at a Public Safety-Net Teaching Hospital: A Retrospective Cohort Analysis

Michael Daunov, Katherine Ann Daunov, Jiasheng Wang, John Eric Fisher, Tamila Kindwall-Keller

Blood (2023) 142 (Supplement 1): 7390.

https://doi.org/10.1182/blood-2023-182921

Published: 2023

Journal Articles

Retrospective Comparison of Patients with Chronic Lymphocytic Leukemia Receiving BTK Inhibitors Versus Obinutuzumab/Venetoclax As Frontline Therapy

Jiasheng Wang, Srilatha Dasari, Michael Daunov, Kanithra Sekaran, Yeseong Kim, Brenda W. Cooper

Blood (2022) 140 (Supplement 1): 9889–9890.

https://doi.org/10.1182/blood-2022-167875

Published: 2022

Journal Articles

Autoimmune Hemolytic Anemia and Increased Stroke Risk in the United States: A Population-Based Study

Akram Alkrekshi, Jiasheng Wang, Dina Elantably, Abdul Rahman Al Armashi

Blood (2022) 140 (Supplement 1): 2429–2430.

https://doi.org/10.1182/blood-2022-164776

Published: 2022

Journal Articles

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Leland Metheny, Ronald M. Sobecks, Christina Cho, Jiasheng Wang, Lisa Ciarrone, Paolo F. Caimi, Folashade Otegbeye, Brenda W. Cooper, Molly Gallogly, Ehsan Malek, Aaron T. Gerds, Betty K. Hamilton, Sergio A Giralt, Miguel-Angel Perales, Marcos J.G. de Lima

Blood (2022) 140 (Supplement 1): 1887–1889.

https://doi.org/10.1182/blood-2022-169935

Published: 2022

Journal Articles

Racial Disparities in Mortality Trends from Acute Myeloid Leukemia: A Population-Based Study in the United States between 2000 and 2019

Abdul Rahman Al Armashi, Anas Al Zubaidi, Dina Elantably, Jiasheng Wang, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 1438.

https://doi.org/10.1182/blood-2022-171171

Published: 2022

Journal Articles

Real-World Evidence of Incidence and Outcomes of Aplastic Anemia Following Administration of Immune Checkpoint Inhibitors

Srilatha Dasari, William Tse, Jiasheng Wang

Blood (2022) 140 (Supplement 1): 712–713.

https://doi.org/10.1182/blood-2022-168353

Published: 2022

Journal Articles

Race-Specific Mortality from Multiple Myeloma: A CDC Database Population Study in the United States between 2000 and 2020

Anas Al Zubaidi, Abdul Rahman Al Armashi, Dina Elantably, Jiasheng Wang, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 10045.

https://doi.org/10.1182/blood-2022-171155

Published: 2022

Journal Articles

Dynamics and Predictive Value of T-Cell Chimerism after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Jiasheng Wang, Benjamin Tomlinson, Ehsan Malek, Leland Metheny, Molly Gallogly, Marcos de Lima, Merle Kolk, Brenda W. Cooper

Blood (2022) 140 (Supplement 1): 12831–12832.

https://doi.org/10.1182/blood-2022-163589

Published: 2022

Journal Articles

The Risk of Cerebrovascular Accident in Patients with Myelodysplastic Syndrome in the United States: A Nationwide Population-Based Study

Dina Elantably, Jiasheng Wang, Abdul Rahman Al Armashi, Nabil El Hage Chehade, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 4065–4066.

https://doi.org/10.1182/blood-2022-165582

Published: 2022

Journal Articles

The Risk of Stroke and Myocardial Infarction in Multiple Myeloma: A Population-Based Study in the United States

Abdul Rahman Al Armashi, Dina Elantably, Jiasheng Wang, Anas Al Zubaidi, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 7226–7227.

https://doi.org/10.1182/blood-2022-166847

Published: 2022

Journal Articles

Response Kinetics of Daratumumab-Based Regimens in Patients with Newly Diagnosed or Refractory/Relapsed Multiple Myeloma

Jiasheng Wang, Raul Arroyo-Suarez, William Tse

Blood (2021) 138 (Supplement 1): 3806.

https://doi.org/10.1182/blood-2021-149315

Published: 2021

Journal Articles

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

Xian Zhang, MD, Jiasheng Wang, Yue Liu, Junfang Yang, Jingjing Li, Gailing Zhang, MD, Yanze Shi, Jiujiang He, Dan Song, Wenqian Li, Shulian Xia, Min Zhang, Zhixiao Zhou, Lemei Jia, Hongli Zheng, Xin Lin, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136833

Published: 2020

Journal Articles

Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay

Jiasheng Wang, MD, Kirsten M Boughan, DO, Paolo F Caimi, MD, Brenda Cooper, MD, Marcos de Lima, MD, Molly M Gallogly, MD PhD, Ehsan Malek, MD, Leland Metheny, III, MD, Folashade Otegbeye, MBBChir,MPH, Shufen Cao, Pingfu Fu, PhD, Benjamin Tomlinson, MD

Blood (2019) 134 (Supplement_1): 2607.

https://doi.org/10.1182/blood-2019-131293

Published: 2019

Journal Articles

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Yongxian Hu, MD PhD, Jiasheng Wang, MD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Jian Yu, MD, Yi Luo, MD, Jimin Shi, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 2691.

https://doi.org/10.1182/blood-2018-99-117910

Published: 2018

Journal Articles

Quantification of Non-Hodgkin Lymphoma Disease Burden Using FDG PET-CT Helps Predict the Severity of Cytokine Release Syndrome

Jiasheng Wang, MD, Yongxian Hu, MD PhD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex Hongsheng Chang, Kui Zhao, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 2997.

https://doi.org/10.1182/blood-2018-99-117983

Published: 2018

Journal Articles

Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk Patients

Yi Luo, Yamin Tan, Yongxian Hu, Jimin Shi, Weiyan Zheng, Yanmin Zhao, Yuanyuan Zhu, Jian Yu, Jiasheng Wang, He Huang, MD PhD

Blood (2016) 128 (22): 3439.

https://doi.org/10.1182/blood.V128.22.3439.3439

Published: 2016

NARROW

Incidence and Outcomes of Pneumocystis Pneumonia Following Chimeric Antigen Receptor T-Cell Therapy: A Real-World Analysis

Social Determinants of Health (SDoH) Scores for Adolescent and Young Adults (AYAs) at a Public Safety-Net Teaching Hospital: A Retrospective Cohort Analysis

Retrospective Comparison of Patients with Chronic Lymphocytic Leukemia Receiving BTK Inhibitors Versus Obinutuzumab/Venetoclax As Frontline Therapy

Autoimmune Hemolytic Anemia and Increased Stroke Risk in the United States: A Population-Based Study

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Racial Disparities in Mortality Trends from Acute Myeloid Leukemia: A Population-Based Study in the United States between 2000 and 2019

Real-World Evidence of Incidence and Outcomes of Aplastic Anemia Following Administration of Immune Checkpoint Inhibitors

Race-Specific Mortality from Multiple Myeloma: A CDC Database Population Study in the United States between 2000 and 2020

Dynamics and Predictive Value of T-Cell Chimerism after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

The Risk of Cerebrovascular Accident in Patients with Myelodysplastic Syndrome in the United States: A Nationwide Population-Based Study

The Risk of Stroke and Myocardial Infarction in Multiple Myeloma: A Population-Based Study in the United States

Response Kinetics of Daratumumab-Based Regimens in Patients with Newly Diagnosed or Refractory/Relapsed Multiple Myeloma

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Quantification of Non-Hodgkin Lymphoma Disease Burden Using FDG PET-CT Helps Predict the Severity of Cytokine Release Syndrome

Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only